Pharming Group N.V. Files 6-K with Press Release
Ticker: PHAR · Form: 6-K · Filed: May 8, 2025 · CIK: 1828316
| Field | Detail |
|---|---|
| Company | Pharming Group N.V. (PHAR) |
| Form Type | 6-K |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, press-release
TL;DR
Pharming Group N.V. dropped a 6-K with a press release on May 8, 2025. Check it for updates.
AI Summary
Pharming Group N.V. filed a Form 6-K on May 8, 2025, to furnish a press release dated May 8, 2025. The filing itself does not contain specific financial figures or operational updates beyond referencing the attached press release.
Why It Matters
This filing indicates that Pharming Group N.V. is providing updated information to the SEC, likely containing important business developments or financial results that investors should review.
Risk Assessment
Risk Level: low — The filing is a standard disclosure of a press release and does not contain inherently risky information.
Key Players & Entities
- Pharming Group N.V. (company) — Registrant
- May 8, 2025 (date) — Filing and Press Release Date
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to furnish a press release dated May 8, 2025, as required by SEC regulations for foreign private issuers.
What is the filing date of this Form 6-K?
The Form 6-K was filed as of May 8, 2025.
What is the exact name of the company filing this report?
The exact name of the company is Pharming Group N.V.
What exhibit is attached to this Form 6-K?
Exhibit 99.1, a press release of Pharming Group N.V. dated May 8, 2025, is furnished as part of this Report on Form 6-K.
Does Pharming Group N.V. file annual reports under Form 20-F or 40-F?
Pharming Group N.V. files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 8, 2025 regarding Pharming Group N.V. (PHAR).